The INNOTEST β-AMYLOID(1-42) is a solid-phase enzyme immunoassay for the quantitative determination of β-amyloid(1-42) in human cerebrospinal fluid (CSF).

The combined use of CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression.

Features & Benefits                   

• User-friendly enzyme  immunoassay, standard technology
• Generic and colour-coded components
• Easily automated on microplate processor (generic components)
• Ready-to-use Calibrators reduce inter and intra run variation
• Run Validation Controls for assay run validation
• Sample volume: 25 µL CSF. Duplicate testing is strongly recommended and requires 2 x 25 µL CSF.
• Limit of Detection: 65 pg/mL
  Calibrator range: 62,5 to 4000 pg/mL
• This assay should be used in combination with the Aβ(1-42) CAL-RVC pack, article no. 81577.
• This assay can also be used in combination with the INNOTEST β-AMYLOID(1-42) HS Conj, article no. 81587 (RUO*) for the quantitative determination of β-amyloid(1-42) in plasma and cell culture supernatants. Use of INNOTEST β-Amyloid article no. 81576 in combination with INNOTEST β-Amyloid(1-42) HS Conj and Aβ(1-42) CAL-RVC pack article no. 81577, implies that no diagnostic claims can be made.

* For research use only. Not for use in diagnostic procedures.

For more information, visit Fujirebio.com.